LOSEC TABLET (DELAYED-RELEASE) কানাডা - ইংরেজি - Health Canada

losec tablet (delayed-release)

cheplapharm arzneimittel gmbh - omeprazole (omeprazole magnesium) - tablet (delayed-release) - 20mg - omeprazole (omeprazole magnesium) 20mg - proton-pump inhibitors

SUPREFACT SOLUTION কানাডা - ইংরেজি - Health Canada

suprefact solution

cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - solution - 100mcg - buserelin (buserelin acetate) 100mcg - antineoplastic agents

SUPREFACT SOLUTION কানাডা - ইংরেজি - Health Canada

suprefact solution

cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - solution - 1mg - buserelin (buserelin acetate) 1mg - antineoplastic agents

VISUDYNE POWDER FOR SOLUTION কানাডা - ইংরেজি - Health Canada

visudyne powder for solution

cheplapharm arzneimittel gmbh - verteporfin - powder for solution - 15mg - verteporfin 15mg - eent drugs, miscellaneous

LOSEC MUPS TABLET (DELAYED-RELEASE) কানাডা - ইংরেজি - Health Canada

losec mups tablet (delayed-release)

cheplapharm arzneimittel gmbh - omeprazole (omeprazole magnesium) - tablet (delayed-release) - 10mg - omeprazole (omeprazole magnesium) 10mg - proton-pump inhibitors

LOSEC MUPS TABLET (DELAYED-RELEASE) কানাডা - ইংরেজি - Health Canada

losec mups tablet (delayed-release)

cheplapharm arzneimittel gmbh - omeprazole (omeprazole magnesium) - tablet (delayed-release) - 20mg - omeprazole (omeprazole magnesium) 20mg - proton-pump inhibitors

Eucardic 12.5 mg Tablets আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

eucardic 12.5 mg tablets

cheplapharm arzneimittel gmbh - carvedilol - tablet - 12.5 milligram(s) - alpha and beta blocking agents; carvedilol

Eucardic 25 mg Tablets আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

eucardic 25 mg tablets

cheplapharm arzneimittel gmbh - carvedilol - tablet - 25 milligram(s) - alpha and beta blocking agents; carvedilol

Eucardic 6.25 mg Tablets আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

eucardic 6.25 mg tablets

cheplapharm arzneimittel gmbh - carvedilol - tablet - 6.25 milligram(s) - alpha and beta blocking agents; carvedilol

Xeloda ইউরোপীয় ইউনিয়ন - ইংরেজি - EMA (European Medicines Agency)

xeloda

cheplapharm arzneimittel gmbh - capecitabine - colonic neoplasms; breast neoplasms; colorectal neoplasms; stomach neoplasms - antineoplastic agents - xeloda is indicated for the adjuvant treatment of patients following surgery of stage iii (dukes' stage c) colon cancer.xeloda is indicated for the treatment of metastatic colorectal cancer.xeloda is indicated for first-line treatment of advanced gastric cancer in combination with a platinum-based regimen.xeloda in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracycline. xeloda is also indicated as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline-containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.